No thanks, Good Luck to you and those who still think that will help.
For me it is not about luck anymore. I am certain for myself that we have something in the science. So, it will not be about luck, but about whether this management intends to translate that to value for share holders or an opportunity for "our" BIG pharma "partners". From what I have seen in the last year, I feel it is reasonable to question that.
Ann: Immutep Investor Presentation, page-10
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
-0.010(2.47%) |
Mkt cap ! $573.7M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 40.8¢ | 39.0¢ | $1.291M | 3.270M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 160217 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 119125 | 4 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |